Inspira Technologies Oxy B.H.N. Ltd. (IINN): שווי שוק להכנסות

Inspira Technologies Oxy produces smart oxygenation devices featuring AI-driven perfusion control. This P/S ratio chart illustrates the business valuation relative to sales, where the indicator stands at 56.30. The company's stability is underpinned by the constant demand for respiratory support. Growth prospects are based on the implementation of non-intubated artificial respiration systems, which are transforming intensive care medicine.

When screening issuer reliability, the P/S ratio serves as a key filter for assessing market value relative to generated revenue. The multiple is calculated as the ratio of market capitalization to annual sales volume, measuring the premium the market is willing to pay per unit of revenue. For Inspira Technologies Oxy (IINN), given its pre-revenue stage and focus on a single oxygenation device, this metric reflects speculative expectations of future breakthroughs. Analyzing the price-to-sales multiple history allows for the timely detection of pricing anomalies before official reports are published.